Table of Contents

Laboratory of Immunology

Home | Research | Staffs | Contact | Publications and Patents

Invalid Link

PROFESSIONAL EXPERIENCE:

2011- Researcher, Immunology laboratory, Chulabhorn Research Institute, Bangkok, Thailand
2009-2010Postdoc fellowship University of Caifornia, San Francisco (2 years), USA
2003 -2008Researcher, National Center for Genetic Engineering and Biotechnology, Pathumthani, Thailand
1998-1999Lecturer, Faculty of Medical Technology, Huachiew Chalermprakiet University, Samutprakarn, Thailand
1994-1995Medical Technologist, Mayo Hospital, Thailand


AWARDS:

2006Awardee of Young Scientist Program (YSP), International Union of Biochemistry and Molecular Biology (IUBMB), 2006, Japan.
1999-2003Scholarship from the Ministry of Education, Science, Sports and Culture of Japan (Monbusho).
1997Scholarship from Mahidol University for training at Department of Biotechnology, Graduate School of Engineering, Osaka University, Japan
1995-1997Scholarship for Graduate Student from the National Science and Technology Development Agency (NSTDA) and Mahidol University.
1990-1992 Scholarship for undergraduate student, Khon Kaen University, Thailand.


List of pubplications

Tumor suppressive monoclonal antibody belonging to the V(H) 7183 family directed to the oncodevelopmental carbohydrate antigen on human hepatocellular carcinoma.
Sandee D, Tungpradabkul S, Laohathai K, Punyammalee B, Kohda K, Takagi M, Imanaka T
J Biosci Bioeng93p266-73(2002)

Construction and high cytoplasmic expression of a tumoricidal single-chain antibody against hepatocellular carcinoma.
Sandee D, Tungpradabkul S, Tsukio M, Imanaka T, Takagi M
BMC Biotechnol2p16(2002 Sep 12)

Construction of scFv derived from a tumor-associated monoclonal antibody having tumoricidal activity on human hepatocellular carcinoma.
Tungpradabkul S, Sandee D, Puthong S, Laohathai K
Mol Immunol42p713-9(2005 Apr)

Combination of Dsb coexpression and an addition of sorbitol markedly enhanced soluble expression of single-chain Fv in Escherichia coli.
Sandee D, Tungpradabkul S, Kurokawa Y, Fukui K, Takagi M
Biotechnol Bioeng91p418-24(2005 Aug 20)

Hypertension in renal parenchymal disease: why is it so resistant to treatment?
Campese VM, Mitra N, Sandee D
Kidney Int69p967-73(2006 Mar)

Up-regulation of microsomal prostaglandin E synthase-1 in COX-1 and COX-2 knock-out mouse fibroblast cell lines.
Sandee D, Sivanuntakorn S, Vichai V, Kramyu J, Kirtikara K
Prostaglandins Other Lipid Mediat88p111-6(2009 Apr)

Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro.
Sandee D, Morrissey K, Agrawal V, Tam HK, Kramer MA, Tracy TS, Giacomini KM, Miller WL
Pharmacogenet Genomics20p677-86(2010 Nov)

Consequences of POR mutations and polymorphisms.
Miller WL, Agrawal V, Sandee D, Tee MK, Huang N, Choi JH, Morrissey K, Giacomini KM
Mol Cell Endocrinol336p174-9(2011 Apr 10)

High-yield expression of a catalytically active membrane-bound protein: human P450 oxidoreductase.
Sandee D, Miller WL
Endocrinology152p2904-8(2011 Jul)

Effect of P450 oxidoreductase variants on the metabolism of model substrates mediated by CYP2C9.1, CYP2C9.2, and CYP2C9.3.
Subramanian M, Agrawal V, Sandee D, Tam HK, Miller WL, Tracy TS
Pharmacogenet Genomics22p590-7(2012 Aug)


INTERNATIONAL PRESENTATIONS: